Altamira Therapeutics
在场
Altamira Therapeutics 是一家在股票代码 EARS (CH) 下上市的公司。
高管
查看带有其 7 名主要高管的组织结构图
Altamira Therapeutics 搜索最多的简介
- Thomas Meyer, Chief Executive Officer and Chairman of the Board
- Alain Munoz, Director
- Dominik Lysek, Director
创建提醒
跟踪 Altamira Therapeutics 的高管变动
药店
Altamira Therapeutics 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
Altamira Therapeutics 的最新新闻稿
- Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business | Altamira Therapeutics
- Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistine | Altamira Therapeutics
- Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis | Altamira Therapeutics
- Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results | Altamira Therapeutics
- Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th | Altamira Therapeutics
- Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13 | Altamira Therapeutics
- Altamira Therapeutics and Pharma Nordic Collaborate for Marketing and Distribution of Bentrio in Scandinavia | Altamira Therapeutics
- Altamira Therapeutics Announces Publication of Positive Results from Clinical Trial with Bentrio in House Dust Mite Allergy in Leading Peer Reviewed Journal | Altamira Therapeutics
- Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering | Altamira Therapeutics
- Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration | Altamira Therapeutics
- View more press releases Close
通过电子邮件
